Despite technical advances in Medically Assisted Reproduction (AMP), the success of fertility treatments is sometimes limited by embryo implantation failure. The coordinated development of the embryo and the uterine endometrium requires close communication between the maternal tissue and the embryo. In in vitro fertilization (IVF), embryo transfer generally takes place between the 2nd (D2) and the 6th (D6) day following oocyte fertilization. Recent studies have shown the advantages of sequential transfer (transfer of an embryo on D2/D3 followed by the transfer of another embryo on D5/D6), with higher implantation and clinical pregnancy rate, fewer miscarriages, more live births, and yet no increase in multiple pregnancies. However, the American Society for Reproductive Medicine recommendations continue to prioritize the transfer of a single embryo for all patients aged under 38. To improve pregnancy rates for patients having a single embryo transferred, the study investigators wish to carry out on "blank" transfer, based on the principle of sequential transfer. The study investigators hypothesize that a culture medium, placed in the uterus before the time of embryo transfer, will modify immune tolerance. The study will test whether transferring the same culture medium in an equivalent quantity as during the real transfer into the uterus 2/3 days before the embryo transfer will improve tolerance to this foreign medium and, therefore, embryo implantation. The aim of this study is thus to evaluate the impact of a "blank" transfer with culture medium alone, on the results of frozen embryo transfers (FET) from IVF.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Enrollment
1,154
A maximum of 0.1 ml of gassed embryo culture medium preheated to 37°C is injected into the uterine cavity transcervically using an embryo transfer catheter placed just beyond the internal os, two to 3 days before transfer of the thawed embryo
An intermediate transfer step is added two or three days before the planned transfer of the frozen embryo but with an empty catheter.
Hôpital Antoine Béclère
Clamart, France
NOT_YET_RECRUITINGCentre Hospitalier Alpes Léman
Contamine-sur-Arve, France
NOT_YET_RECRUITINGCHU Arnaud de Villeneuve
Montpellier, France
NOT_YET_RECRUITINGClinique Saint Roch
Montpellier, France
NOT_YET_RECRUITINGCHU de Nîmes
Nîmes, France
RECRUITINGClinique Saint-Pierre
Perpignan, France
NOT_YET_RECRUITINGCHU de la Réunion
Saint-Pierre, Reunion
NOT_YET_RECRUITINGClinically progressive pregnancy rate between groups
Measured on first-trimester ultrasound
Time frame: 12 weeks of amenorrhea
Occurrence of pregnancy between groups
Defined by a positive beta HCG test ≥ 100 IU/ml
Time frame: Day 14
Occurrence of a biochemical pregnancy between groups
Defined by a positive beta HCG test ≥ 10 IU/ml and \< 100 IU/ml
Time frame: Day 14
Occurrence of a clinical pregnancy between groups
Defined by a positive beta HCG test ≥ 100 IU/ml and presence of at least one gestational sac on dating ultrasound
Time frame: 6 weeks of amenorrhea
Occurrence of an early miscarriage between groups
Defined by the presence of a pregnancy defined by a positive beta HCG test ≥ 100 IU at D14 and the absence of an evolving clinical pregnancy at first-trimester ultrasound
Time frame: 12 weeks of amenorrhea
Occurrence of live birth
Yes/no
Time frame: Upon giving birth (maximum month 9)
Differential cost-result ratio
Ratio of the cost differential and the number of additional live births (additional progressive clinical pregnancies) between the two strategies, to evaluate the cost per additional live birth.
Time frame: End of study (Year 3)
Total estimated expenditure for the two care strategies compared (budget impact analysis) over a one-year time horizon.
Calculated at national level (implementation of the system and consumption of care)
Time frame: End of study (Year 3)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.